Skip to main content
PolicySpeak
← All files
LAB

Labcorp

Company · United States · EU Transparency Register 878238423039-24

2
positions filed
in the 665 files tracked
1
legislative file
of 665 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 1210 companies & groups on this site, they rank #804 by legislative files engaged, a count of participation, not a measure of influence.

1.5
declared lobbying FTE
self-declared
€100K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2016
in the register since

Declares membership of

Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).

Register category
Companies & groups
Registered as
Laboratory Corporation of America Holdings (Labcorp)
Head office
Burlington, United states
EU office
Mechelen

Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Labcorp in PolicySpeak: request access →

Follow Labcorp

An email when this organization files on a consultation we publish.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Work at Labcorp? so we know who speaks for it.

Their record over time

Labcorp filed 2 positions between 6 Oct 2025 and 9 Apr 2026, across 1 of the 665 legislative files tracked here.

2025 · 1 filed2026 · 1 filed

What they argued

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 9 Apr 2026source

Labcorp is a global leader in innovative laboratory services and the market leader in central laboratory services (CLS) supporting EU-based clinical trials through t testing samples from EU patients. Biotech and pharma rely on CLS to provide the highest level of global data consistency, crucial to multinational clinical trials Labcorp welcomes the Commissions proposal to streamline and simplify the MDR and IVDR…

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 6 Oct 2025source

Labcorp is a global leader in innovative laboratory services and the market leader in central laboratory (CL) testing services. We have a strong R&D footprint in Europe, and our CL in Switzerland analyses samples from clinical trial patients in EMEA. A CL is a laboratory where specimen samples from clinical trial patients are analysed to guide decisions on clinical trials and patient management.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put Labcorp next to another organization. Same files, same register facts, side by side. Compare →

Is this your organization?

Everything on this page comes from Labcorp’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.